Brief: China Biotech Services Expects Consolidated Net Profit Attributable Of Not Less Than HK$17 Mln For Year
07/03/2022 15:21
March 7 (Reuters) - China Biotech Services Holdings Ltd
8037.HK :
* EXPECTS TO RECORD A CONSOLIDATED NET PROFIT ATTRIBUTABLE
OF NOT
LESS THAN HK$17 MILLION FOR YEAR
* EXPECTED RESULTS ON MILD DECREASE IN 2021 YEAR'S REVENUE
FROM
MEDICAL LABORATORY TESTING AND HEALTH CHECK SERVICES SEGMENT
Further company coverage: 8037.HK
Recent news on China Biotech Services Holdings
See all newsBrief: China Biotech Services Enters Cooperation Agreement
Brief: China Biotech Services Says HY Revenue From Cont Ops Hk$37.23 Million
Brief: China Biotech Services Expects HY Net Profit Of Not Less Than HK$15.0 MLN
Brief: China Biotech Services Enters Master Collaboration Agreement With Stella Pharma
Brief: China Biotech Services Says BGI Songhe Advances RMB30 Million Loan To Pengbo (Hainan)